<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>SCHEDULE 13G</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001441449</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>


        </filerInfo>
    </headerData>
    <formData>
        <coverPageHeader>
            <securitiesClassTitle>Common Stock SH CL B</securitiesClassTitle>
            <eventDateRequiresFilingThisStatement>02/04/2026</eventDateRequiresFilingThisStatement>
            <issuerInfo>
                <issuerCik>0000728387</issuerCik>
                <issuerName>Perspective Therapeutics Inc</issuerName>
                <issuerCusip>46489V302</issuerCusip>
                <issuerPrincipalExecutiveOfficeAddress>
                    <com:street1>24301 Elliot Avenue, Suite 320</com:street1>
                    <com:city>Seattle</com:city>
                    <com:stateOrCountry>WA</com:stateOrCountry>
                    <com:zipCode>98121</com:zipCode>
                </issuerPrincipalExecutiveOfficeAddress>
            </issuerInfo>
            <designateRulesPursuantThisScheduleFiled>
                <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
            </designateRulesPursuantThisScheduleFiled>
        </coverPageHeader>
        <coverPageHeaderReportingPersonDetails>

            <reportingPersonName>Qatar Investment Authority</reportingPersonName>
            <memberGroup>b</memberGroup>
            <citizenshipOrOrganization>S3</citizenshipOrOrganization>
            <reportingPersonBeneficiallyOwnedNumberOfShares>
                <soleVotingPower>7073308.00</soleVotingPower>
                <sharedVotingPower>0.00</sharedVotingPower>
                <soleDispositivePower>7073308.00</soleDispositivePower>
                <sharedDispositivePower>0.00</sharedDispositivePower>
            </reportingPersonBeneficiallyOwnedNumberOfShares>
            <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>7073308.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
            <classPercent>6.2</classPercent>
            <typeOfReportingPerson>OO</typeOfReportingPerson>
        </coverPageHeaderReportingPersonDetails>
        <items>
            <item1>
                <issuerName>Perspective Therapeutics Inc</issuerName>
                <issuerPrincipalExecutiveOfficeAddress>24301 Elliot Avenue, Suite 320, Seattle, Washington, 98121</issuerPrincipalExecutiveOfficeAddress>
            </item1>
            <item2>
                <filingPersonName>Qatar Investment Authority</filingPersonName>
                <principalBusinessOfficeOrResidenceAddress>Ooredoo Tower (Building 14), Al Dafna Street (Street 801), Al Dafna (Zone 61), Doha, Qatar</principalBusinessOfficeOrResidenceAddress>
                <citizenship>Qatar</citizenship>
            </item2>
            <item3>
                <notApplicableFlag>Y</notApplicableFlag>
            </item3>
            <item4>
                <amountBeneficiallyOwned>7,073,308</amountBeneficiallyOwned>
                <classPercent>6.2</classPercent>
                <numberOfSharesPersonHas>
                    <solePowerOrDirectToVote>7,073,308</solePowerOrDirectToVote>
                    <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
                    <solePowerOrDirectToDispose>7,073,308</solePowerOrDirectToDispose>
                    <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
                </numberOfSharesPersonHas>
            </item4>
            <item5>
                <notApplicableFlag>Y</notApplicableFlag>
                <classOwnership5PercentOrLess>N</classOwnership5PercentOrLess>
            </item5>
            <item6>
                <notApplicableFlag>Y</notApplicableFlag>
            </item6>
            <item7>
                <notApplicableFlag>N</notApplicableFlag>
                <subsidiaryIdentificationAndClassification>Q Healthcare Holding LLC is the wholly owned subsidiary of Qatar Investment Authority that acquired the security.  </subsidiaryIdentificationAndClassification>
            </item7>
            <item8>
                <notApplicableFlag>Y</notApplicableFlag>
            </item8>
            <item9>
                <notApplicableFlag>Y</notApplicableFlag>
            </item9>
            <item10>
                <notApplicableFlag>N</notApplicableFlag>
                <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. </certifications>
            </item10>
        </items>
        <signatureInformation>
            <reportingPersonName>Qatar Investment Authority</reportingPersonName>
            <signatureDetails>
                <signature>Mohammed Fahad Al Khulaifi</signature>
                <title>Head of Compliance</title>
                <date>02/05/2026</date>
            </signatureDetails>
        </signatureInformation>
    </formData>
</edgarSubmission>
